MINNA DELUCA: Open Payments
NPI 1114397304 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 27 payments from 16 companies in 2025. Trend: 2023 $1,070 · 2024 $532 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| ABBVIE INC. | 3 | $56 |
| Antares Pharma, Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Abbott Laboratories | 2 | $38 |
| Intra-Sana Laboratories | 2 | $31 |
| Currax Pharmaceuticals LLC | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: CAPLYTA, REXULTI, VRAYLAR, XYOSTED, FREESTYLE LIBRE 3, RELTONE 200 MG, CONTRAVE, SPRAVATO.
Industry payments across TN — which companies pay providers there.
